BGI Genomics Co., Ltd. (SHE:300676)
China flag China · Delayed Price · Currency is CNY
40.28
-0.94 (-2.28%)
Apr 28, 2026, 3:04 PM CST

BGI Genomics Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
15,82217,41116,00519,67621,18835,990
Market Cap Growth
-21.81%8.78%-18.66%-7.14%-41.13%-29.32%
Enterprise Value
13,17314,51111,83714,56814,55728,800
Last Close Price
41.2245.3641.9747.8650.6785.65
PE Ratio
---211.8026.3924.63
Forward PE
-25.0925.0925.0925.0935.26
PS Ratio
4.124.704.144.523.005.32
PB Ratio
1.852.021.731.972.073.81
P/TBV Ratio
1.982.161.832.102.203.99
P/FCF Ratio
-----17.20
P/OCF Ratio
103.73-167.2148.14161.8914.54
EV/Sales Ratio
3.433.923.063.352.064.26
EV/EBITDA Ratio
---30.1811.5314.70
EV/EBIT Ratio
---128.9816.0817.14
EV/FCF Ratio
-36.99----13.76
Debt / Equity Ratio
0.070.070.050.040.020.09
Debt / EBITDA Ratio
---0.660.150.41
Debt / FCF Ratio
-----0.41
Net Debt / Equity Ratio
-0.32-0.36-0.41-0.51-0.61-0.83
Net Debt / EBITDA Ratio
51.8222.9912.52-10.65-4.91-3.98
Net Debt / FCF Ratio
7.755.528.856.225.46-3.73
Asset Turnover
0.320.310.300.310.490.53
Inventory Turnover
4.904.503.933.344.423.02
Quick Ratio
2.312.172.132.132.232.94
Current Ratio
2.602.422.422.412.473.26
Return on Equity (ROE)
-6.67%-7.13%-9.46%0.93%8.23%19.11%
Return on Assets (ROA)
-2.71%-3.06%-3.52%0.50%3.95%8.25%
Return on Invested Capital (ROIC)
-9.22%-10.91%-14.31%2.06%25.71%79.94%
Return on Capital Employed (ROCE)
-5.70%-6.50%-7.60%1.10%8.70%15.50%
Earnings Yield
-3.62%-3.54%-5.64%0.47%3.79%4.06%
FCF Yield
-2.25%-3.27%-2.71%-4.21%-5.36%5.81%
Dividend Yield
---0.21%1.97%0.41%
Payout Ratio
---448.58%20.82%12.16%
Buyback Yield / Dilution
-0.98%-0.96%-0.01%-0.48%0.32%-3.11%
Total Shareholder Return
-0.98%-0.96%-0.01%-0.27%2.29%-2.70%
Updated Mar 31, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.